Abstract: A computer-implemented system includes a treatment apparatus manipulated by a patient while performing an exercise session and a patient interface that receives a virtual avatar. The patient interface presents the virtual avatar. The virtual avatar uses a virtual representation of the treatment apparatus to guide the patient through an exercise session. A server computing device provides the virtual avatar of the patient to the patient interface and receives a message pertaining to a trigger event. The message includes a severity level of the trigger event. The server computing device determines whether a severity level of the trigger event exceeds a threshold severity level, and responsive to determining the severity level of the trigger event exceeds the threshold severity level, replaces on the patient interface the presentation of the virtual avatar with a presentation of a multimedia feed from a computing device of the medical professional.

Abstract: A vehicle and components thereof are provided. The vehicle can include an apparatus having a shelving module, a post, and a mechanism.

Abstract: A vehicle and components thereof are provided. The vehicle can include an apparatus having a shelving module, a post, and a mechanism.

Abstract: A vehicle and components thereof are provided. The vehicle can include an apparatus having a shelving module, a post, and a mechanism.

Abstract: In one embodiment, a method is disclosed. The method includes, while the patient uses the treatment apparatus, controlling, based on a treatment plan for a patient, a treatment apparatus. The method includes receiving, by a processing device, data from an electronic device, wherein the data comprises one of a position of a body part of the patient or a force exerted by the body part. The method includes storing, via the processing device, the data for the patient in a computer-readable medium. The method includes causing, via a processing device, presentation of a user interface on a patient interface. The user interface comprises an adjustment confirmation control, and the adjustment confirmation control is configured to solicit a response regarding the patient's comfort level with the one of the position of the body part or the force exerted by the body part.

Abstract: A multi core optical fiber that includes a plurality of cores disposed in a cladding. The plurality of cores include a first core and a second core. The first core has a first propagation constant ?1, the second core has a second propagation constant ?2, the cladding has a cladding propagation constant ?0, and (I).

Abstract: A computer-implemented system may include a treatment device configured to be manipulated by a user while the user is performing a treatment plan and a patient interface comprising an output device configured to present telemedicine information associated with a telemedicine session. The computer-implemented system may also include a first computing device configured to: receive treatment data pertaining to the user while the user uses the treatment device to perform the treatment plan; write to an associated memory, for access by an artificial intelligence engine, the treatment data; receive, from the artificial intelligence engine, at least one prediction; identify a threshold corresponding to the at least one prediction; and, in response to a determination that the at least one prediction is outside of the range of the threshold, update the treatment data pertaining to the user to indicate the at least one prediction.

Abstract: The present invention relates to antibodies binding to IL13 and IL22. The invention provides novel multi-specific antibodies that bind to both IL13 and IL22 and compositions comprising an antibody that binds to IL13 and an antibody that binds to IL22. The invention further relates to therapeutic uses of the combination of anti-IL13 and anti-IL22 antibodies and multi-specific antibodies that bind to both IL13 and IL22.

Abstract: In one example embodiment, a computer-implemented method for transporting cargo using smart palettes includes determining receipt of a first cargo onto a platform of a first smart palette at a first distribution hub. The method includes generating one or more signals that control a loading of the first smart palette and the first cargo onto a trailer located at the first distribution hub. The method includes determining a coordination with one or more second smart palettes associated with the trailer to determine a first position inside the trailer for the first smart palette and the first cargo. The method includes generating one or more signals that position the first smart palette and the first cargo at the first position inside the trailer.

Abstract: The present invention relates to the use of cannabidiol (CBD) and an anti-epileptic drug (AED), brivaracetam (BRV), for the treatment of seizures associated with epilepsy syndromes. In particular the types of seizures treated include atonic, tonic, tonic-clonic, and focal seizures with secondary generalisation. Preferably the dose of CBD is between 5 mg/kg/day to 50 mg/kg/day.

Abstract: The present invention relates to the use of cannabidiol (CBD) for the treatment of seizures associated with herpes simplex virus. In a further embodiment the types of seizures include tonic, tonic-clonic, atonic, myoclonic, absence and focal seizures with impairment. Preferably the dose of CBD is between 5 mg/kg/day to 50 mg/kg/day.

Abstract: A smart-home device may include a main power rail that provides power to components of the smart-home device; an integrator coupled to the main power rail that stores energy on an energy-storage device, where the energy stored on the energy-storage device is representative of an amount an amount of power provided to the smart-home device through the main power rail during an integration cycle of the integrator; and a counter that stores a number of integration cycles performed by the integrator during a time interval, where a total amount of power provided to the smart-home device through the main power rail during the time interval is represented by: (1) the number of integration cycles performed by the integrator during the time interval; and (2) the energy stored on the energy-storage device.

Abstract: A microfilter having a hydrophilic surface and suited for size-based capture and analysis of cells, such as circulating cancer cells, from whole blood and other human fluids is disclosed. The filter material is photo-definable, allowing the formation of precision pores by UV lithography. Exemplary embodiments provide a device that combines a microfilter with 3D nanotopography in culture scaffolds that mimic the 3D in vivo environment to better facilitate growth of captured cells.

Abstract: A method of powering a controller using an intermediate device with power from an environmental system may include receiving current from a power wire from the environmental system; passing the current from the power wire to a second command wire from the controller; monitoring the current flowing between the power wire and the second command wire while the current is below a threshold indicative of an amount of current used to power the controller from the environmental system; detecting when the current flowing between the power wire and the second command wire exceeds the threshold indicating that the controller is sending a command to the environmental system to perform the function; and sending a command to environmental system using a first command wire from the environmental system after detecting that the current exceeds the threshold.

Abstract: Systems and methods are disclosed herein for processing a natural language query on data tables. According to some embodiments, a query term is obtained from a natural language query. A table summary is prepared based on the query term and a formula of the natural language query is generated based on the table summary. A result is generated based on the formula. Responsive to receiving negative feedback to the result, one or more of the table summary or the formula is disassociated from the query term.

Abstract: The present invention relates to the use of cannabidiol (CBD) for the treatment of seizures associated with rare epilepsy syndromes. In particular the seizures associated with rare epilepsy syndromes that are treated are those which are experienced in patients diagnosed with encephalocele. In a further embodiment the types of seizures include absence, focal seizures with secondary generalisation and focal seizures with impairment. Preferably the dose of CBD is between 5 mg/kg/day to 50 mg/kg/day.

Abstract: The present invention relates to the use of cannabidiol (CBD) for the treatment of seizures associated with rare epilepsy syndromes. In particular the seizures associated with rare epilepsy syndromes that are treated are those which are experienced inpatients diagnosed with a SPATA5 mutation. In a further embodiment the types of seizures include tonic, myoclonic and focal seizures with impairment. Preferably the dose of CBD is between mg/kg/day to 50 mg/kg/day.